Come visit Asterand Bioscience at these events!
February 6-7, 2017 | San Diego Marriott La Jolla | San Diego, CA, USA
The recent success of companion diagnostics along with the increasing regulatory pressure for better identification of the target population has created an extraordinary spur for drug discovery companies to invest in novel strategies for biomarker discovery. Also, the confluence of immunology and oncology tributaries has triggered a biomarker turbulence that is novel to the cancer community.
The pursuit to drive precision medicine and the quest to refine a biomarker model for immuno-oncology drug development, The 2nd Annual Biomarker Conference aims to gather experts from pharma, bio-pharma companies and research institutes to discuss current challenges and opportunities in biomarker discovery, CDx, NGS, regulatory and reimbursement issues and novel technologies.
February 19-24, 2017 | Moscone North Convention Center | San Francisco, CA, USA
Attracting over 3,500 drug discovery and development professionals from over 40 countries in 2016, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
February 22-23, 2017 | Copthorne Tara Hotel | London, UK
SMi Group proudly presents the inaugural launch of 3D Cell Culture, an exciting new conference. 3D Cell Culture 2017 will bring together leading professionals and researchers in the industry to discuss the latest developments and future potential of this technique. 3D Cell Culture 2017 will present success stories 3D culture applications, identifying the newest and brightest technologies, and the translation of 3D models into successful clinical and industrial applications. There will be emphasis on the success and future of 3D methods in organoid research, disease modeling and toxicology screening, stem cell research, and much more.
February 21-22, 2017 | Bridgewater Marriott | Bridgewater, NJ, USA
February 26-March 1, 2017 | Wellcome Collection Henry Wellcome | London, UK
Join us for two days of presentations discussing the latest advances in the biologics field. Our agenda has been designed to encourage thought-provoking and insightful debate from the industry’s leading experts. Join us at ABS 2017 and benefit from:
- A focus on immune oncology, autoimmune diseases and respiratory diseases. Learn about the latest strategies, data and insights that have really made a difference.
- Practical, case study based presentations meaning you’ll immediately be able to identify similar opportunities in your role.
- An open networking forum for all attendees leading to thought-provoking and stimulating discussions.
- An EU Continuing Professional Development (CPD) accredited agenda. Attend ABS 2017 and take a proactive approach to enhancing your skills and adding to your CPD record.
March 6, 2017 | Wellcome Genome Campus Conference Centre | Cambridge, UK
SMi Group proudly presents the inaugural launch of 3D Cell Culture, an exciting new conference.
3D Cell Culture 2017 will bring together leading professionals and researchers in the industry to discuss the latest developments and future potential of this technique. 3D Cell Culture 2017 will present success stories 3D culture applications, identifying the newest and brightest technologies, and the translation of 3D models into successful clinical and industrial applications. There will be emphasis on the success and future of 3D methods in organoid research, disease modeling and toxicology screening, stem cell research, and much more.
March 20-21 | Wyndham Boston Beacon Hill | Boston, MA, USA
Select Biosciences, Inc. Fourth Annual Circulating Biomarkers World Congress 2017 brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage will include:
- Extracellular Vesicles (EVs): Exosomes and Microvesicles
- Circulating Nucleic Acids: Circulating Cell-Free DNA, Circulating RNAs
- Circulating Rare Cells in the Circulation
- Technologies for Isolation and Characterization
March 29-30 | Novotel London West | London, UK
Through industry defining thought leadership from the movers and shakers of the precision medicine universe, the 7th Annual World CDx Europe Summit showcases field-defining case studies dedicated to laying the roadmap to help you rapidly progress from exploratory biomarker to predictive, efficacious therapy and fully-approved CDx.
April 1-5 | Walter E. Washington Convention Center | Washington, DC, USA
The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research.
April 11 | Harvard Medical School | Boston, MA, USA
The Cancer Advance Boston, organized by the Boston Biotech Conferences will take place on 11th April 2017 at the Harvard Medical School in Boston, United States Of America. The conference will cover areas like healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community and many more.
May 2-4 | Philadelphia Marriott Downtown | Philadelphia, PA, USA
The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies
May 9-12 | Westin Harbour Castle Hotel | Toronto, Canada
More information coming soon, stay tuned!
May 10-11 | AstraZeneca | Gothenburg, Sweden
The program for this ELRIG meeting has been developed to expand scientific horizons in key topic areas such as advanced cell models, applied omics, assays/methods exploring mode of action, phenotypic screening, target deconvolution, and much more. Speakers from leading laboratories, both academic and industrial, will present and discuss the latest updates and advances in cellular systems and drug discovery platforms. Throughout the course of the two day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions with scientists and researchers from the pharmaceutical, academic and vendor communities.
May 17-18 | Cancer Research UK Cambridge Institute | Boston, MA, USA
It is our pleasure to announce the return of our ‘Applications of in situ hybridization in research and disease’ symposium. The symposium, organized by a committee chaired by Dr. Julia Jones, will be held at the Cancer Research UK Cambridge Institute on the 17-18 May 2017. The meeting will highlight advances in in-situ hybridization and it’s application in disease. To achieve these goals we have assembled an outstanding list of world-leading researchers to present their work.
May 21-24 | Loews Hotel | Philadelphia, PA, USA
Over 600 people (including representatives from over 100 sponsors and CROs) will attend. 100+ sessions and workshops in seven tracks: clinical operations, site management, regulatory compliance, contracts, budgets & billing, quality and special topics. Exceptional networking with a broad (but not too broad) range of experienced clinical research professionals
June 2-6 | McCormick Place | Chicago, IL, USA
The Annual Meeting brings together more than 30,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.
June 14-17 | EMBL Advanced Training Centre | Heidelberg, Germany
This symposium will focus on the molecular basis of major neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis, with a strong emphasis on mechanism based drug development. The meeting will cover the various molecular mechanisms linked to these diseases, including RNA biology, nuclear transport, protein processing, protein aggregation and protein folding. The symposium will also address the genetic components underlying neurodegeneration and the involvement of innate immune responses, discuss disease biomarkers and therapeutic options, as well as using animal models for studying neurodegenerative disease.